General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial

General practitioner use of a C-reactive protein point-of-care test to help target antibiotic prescribing in patients with acute exacerbations of chronic obstructive pulmonary disease (the PACE study): study protocol for a randomised controlled trial

Abstract Background Most patients presenting with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) in primary care are prescribed an antibiotic, which may not always be appropriate and may cause harm. C-reactive protein (CRP) is an acute-phase biomarker that can be rapidly measu...

Full description

Bibliographic Details
Main Authors: Janine Bates, Nick A. Francis, Patrick White, David Gillespie, Emma Thomas-Jones, Rachel Breen, Nigel Kirby, Kerry Hood, Micaela Gal, Rhiannon Phillips, Gurudutt Naik, Jochen Cals, Carl Llor, Hasse Melbye, Mandy Wootton, Evgenia Riga, Ann Cochrane, Robin Howe, Deborah Fitzsimmons, Bernadette Sewell, Mohammed Fasihul Alam, Christopher C. Butler
Format: Article
Language:English
Published: BMC 2017-09-01
Series:Trials
Subjects:
Acute exacerbation
Chronic obstructive pulmonary disease
Primary care
Point-of-care test
C-reactive protein (CRP)
Near-patient testing
Online Access:http://link.springer.com/article/10.1186/s13063-017-2144-8

Internet

http://link.springer.com/article/10.1186/s13063-017-2144-8

Similar Items